GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.

about

GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.

Item

http://www.wikidata.org/entity/Q42700718

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.

@en

GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.

@nl

type

Item

label

GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.

@en

GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.

@nl

prefLabel

GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.

@en

GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.

@nl

P1476

GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.

@en

P2093

Dan-Ke Su

http://www.w3.org/2001/XMLSchema#string

Jie Ma

http://www.w3.org/2001/XMLSchema#string

Shao-Liang Zhu

http://www.w3.org/2001/XMLSchema#string

Xiang-Yang Huang

http://www.w3.org/2001/XMLSchema#string

Yang Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review

Global cancer statistics, 2012

Operating characteristics of a rank correlation test for publication bias

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

Genetic predictors of long-term toxicities after radiation therapy for breast cancer.

Effect of GSTP1 and ABCC4 gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-5-fluorouracil-based chemotherapy in Bangladeshi breast cancer patients.

Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.

Glutathione S-transferases--a review.

P304

72939-72949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18513

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29069838

http://www.w3.org/2001/XMLSchema#string

P932

5641181

http://www.w3.org/2001/XMLSchema#string